Cardiovascular Market Research Reports & Industry Analysis
Variations in heart size and position within the chest may be related to age, body size, shape, weight, or pathologic conditions of the heart and other nearby structures.
There has been considerable study into the role of inflammation in heart disease. Researchers have found the first direct evidence that reducing inflammation in coronary arteries decreases the risk of heart attacks as much as reducing cholesterol levels. This finding offers a new approach to preventing heart disease. Two studies showed that inflammation of the arteries can be reduced by more aggressive use of statins. New drugs that target inflammation that are measured by a marker called Creactive rotein (CRP) could have a large impact on cardiovascular health as well as a large financial gain for companies developing these products.
Cardiovascular Industry Research & Market Reports
-
Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Hypercholesterolemia (Metabolic Disorders) pipeline landscape. Hypercholesterolemia is a condition characterized by very high levels of cholesterol in the blood. This leads in formation of sticky deposits (called plaque) along the artery walls. ... Read More
-
Global Acute Ischemic Stroke Therapeutics Market 2023-2027
... the forecast period. Our report on the acute ischemic stroke therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The ... Read More
-
Global Transthyretin Amyloid Cardiomyopathy Market - 2022-2029
... of 31.1 % during the forecast period (2022-2029). Transthyretin amyloid cardiomyopathy is an underdiagnosed and potentially fatal disease. It is characterized by deposits of amyloid protein fibrils in the left ventricle walls, the heart's main ... Read More
-
Global Dilated Cardiomyopathy Therapeutics Market - 2022-2029
... CAGR of 5.90% during the forecast period (2022-2029). Dilated cardiomyopathy (DCM) is an abnormality of the heart muscle, usually starting in your heart's main pumping chamber (left ventricle). The ventricle becomes weakened and enlarged and ... Read More
-
Global Cardiac PoC Testing Devices Market Size study & Forecast, by Product Type (Cardiac Markers Test, Analyzers), by End-Users (Hospitals, Diagnostic Laboratories and Other End-Users), and Regional Analysis, 2022-2029
... is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2022-2029. Cardiac POC testing devices are devices that ... Read More
-
Global Acute Coronary Syndrome Market - 2022-2029
... of 8.74% during the forecast period (2022-2029). Acute coronary syndrome (ASC) occurs when a blood clot suddenly forms within a coronary artery, usually due to the acute rupture of an atherosclerotic plaque. The blood clot ... Read More
-
Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP, hs-CRP), Disease (Myocardial Infarction, Congestive Heart Failure, Atheresclerosis), Enduser (Lab, PoC, Academia) - Global Forecast to 2027
... cardiac marker testing market is projected to reach USD 7.7 Billion by 2027 from USD 5.0 Billion in 2022, at a CAGR of 8.7% during the forecast period. The growth in the cardiac marker testing ... Read More
-
Pediatric Clinical Trials Market, by Clinical Trial Phase (Pre-clinical, Phase I, Phase II, and Phase III), by Study Design (Treatment Studies and Observational Studies), by Medical Condition (Neuropsychiatric Conditions, Infectious Diseases, Maternal and Perinatal Conditions, Respiratory Diseases, Cardiovascular Diseases, Cancer, Digestive Diseases and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Respiratory Diseases, Cardiovascular Diseases, Cancer, Digestive Diseases and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Pediatric clinical trials ... Read More
-
Global Cardiovascular Information System (CVIS) Market Research Report- Forecast till 2027
... to 2027. It has been denoted that the cardiovascular information system market projects at a CAGR of 8.23%. Everywhere, it has been found that because of cardiovascular sickness many individuals have passed on because of ... Read More
-
Atrial Fibrillation Market, by Procedure (Pharmacological (Anti-arrhythmic and Anti-coagulant), Non-Pharmacological (Catheter Ablation Procedures, Maze surgery and Electric Cardioversion), by Technology (Radiofrequency, Laser, Cryotherapy and Others), by End User Hospitals, Speciality, Clinics and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Atrial fibrillation is a type of cardiac arrhythmia distinguished by an abnormal cardiac rhythm ... Read More
-
Statin
... revised size of US$15.2 Billion by 2027, growing at aCAGR of 1.6% over the period 2020-2027. Synthetic, one of the segments analyzed in the report, is projected to record 1.8% CAGR and reach US$10.2 Billion ... Read More
-
Global Precision Cardiology Market By Offering (Products v/s Service), By Sample Type (Blood v/s Non-Blood), By Technology (Sequencing, Polymerase Chain Reaction, Microarray, Others), By Application (Cardiomyopathy, Arrhythmia, Aortopathy and Vascular Diseases, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others) and By Region, Competition Forecast and Opportunities, 2027
... (Hospitals & Clinics, Academic & Research Institutions, Others) and By Region, Competition Forecast and Opportunities, 2027 Global precision cardiology market is anticipated to register growth at an impressive CAGR in the forecast period, 2023-2027. The ... Read More
-
Congestive Heart Failure Market Share, Size, Trends, Industry Analysis Report, By Product (Cardiac Resynchronization Therapy, Counter Pulsation Devices, ICD, Pacemakers, Ventricular Assist Devices, Others); By End-Use; By Region; Segment Forecast, 2022 -
... congestive heart failure market size is expected to reach USD 18.48 billion by 2030, according to a new study by Polaris Market Research. The report “Congestive Heart Failure Market Share, Size, Trends, Industry Analysis Report, ... Read More
-
Global Fitness Equipment Market Size study, by Type (Cardiovascular Training Equipment, Strength Training Equipment, and Other Equipment), by End User (Home Consumer, Health Club/Gym, and Other Commercial User) and Regional Forecasts 2022-2028
... Market is valued approximately USD 11821.67 million in 2021 and is anticipated to grow with a healthy growth rate of more than 3.3 % over the forecast period 2022-2028. The Fitness Equipment can be defined ... Read More
-
Hypertriglyceridemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Hypertriglyceridemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hypertriglyceridemia. Report includes ... Read More
-
Rare Diseases Treatment Market - Global Industry Analysis (2019 - 2021), Growth Trends, and Market Forecast (2022 - 2029)
... 2022 to 2029. Orphan drug development has emerged as the foremost growth enabler across the market, setting the stage for innovation-driven expansion. World over, the incidence of rare diseases and genetic disorders has been increasing, ... Read More
-
Cardiovascular Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $19.1 and in terms of global GDP, the market was 0.16%. Cardiovascular drugs was the fourth largest segment within the market accounting for 10.0% preceded and followed by central nervous ... Read More
-
Medical Tubing Market Forecasts to 2028 – Global Analysis By Product Type (Single Lumen Tubing, Multi-Lumen Tubing), Material (Plastics, Rubbers, Specialty polymers, Metal, Others), Material (Force Spinning, Magneto Spinning, Rotary Jet Spinning, Others), Structure (Single-lumen, Co-extruded, Multi-lumen, Tapered or bump tubing, Braided tubing, Balloon, Microextrusion, Heat Shrink, Thin-Walled, Coiled, High-Pressure), Medical Condition (Gastrointestinal, Cardiovascular, Ophthalmic, Urological, Neurovascular, Others)Application, End User and By Geography
... Co-extruded, Multi-lumen, Tapered or bump tubing, Braided tubing, Balloon, Microextrusion, Heat Shrink, Thin-Walled, Coiled, High-Pressure), Medical Condition (Gastrointestinal, Cardiovascular, Ophthalmic, Urological, Neurovascular, Others)Application, End User and By GeographyAccording to Stratistics MRC, the Global Medical Tubing ... Read More
-
Global Cardiovascular Ultrasound System Market Research Report 2022-2032
... sales, forecast trends, supply, production, demands, industry, and CAGR to provide a comprehensive outlook of the global. Additionally, the report also highlights the challenges impeding growth and expansion strategies employed by leading companies in the ... Read More
-
North America Cardiovascular Ultrasound Market 2022-2028
... 2022 and 2028. The United States and Canada are analyzed in the market in this region. Earlier, hospital admissions for cardiovascular diseases in Canada were significantly lesser. However, in recent years, hospitalizations for these ailments ... Read More
-
Hypertrophic Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Hypertrophic Cardiomyopathy (Cardiovascular) pipeline landscape. Hypertrophic cardiomyopathy (HCM) is a disease in which the heart muscle (myocardium) becomes abnormally thick (hypertrophied). The thickened heart muscles make it harder for the ... Read More
-
Atherosclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Atherosclerosis (Cardiovascular) pipeline landscape. Atherosclerosis (or arteriosclerotic vascular disease) is a condition where the arteries become narrowed and hardened due to an excessive build up of plaque around the artery wall. The ... Read More
-
Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Stroke (Cardiovascular) pipeline landscape. Stroke is a condition in which the brain cells suddenly die because of a lack of oxygen. Symptoms occur rapidly and usually last a short time, from a ... Read More
-
Global Thrombectomy Devices Market Size study, by Type (Hydrodynamic, Ultrasound, Aspiration, Mechanical Thrombectomy), by Application (Cardiovascular, Peripheral, Neurovascular), by End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs) and Regional Forecasts 2022-2028
... is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Thrombectomy device is an intracoronary catheter ... Read More
-
Nuclear Medicine/Radiopharmaceuticals Market Analysis And Forecast To 2031: By Type (Diagnostics, {SPECT, PET}, Therapeutics {Alpha Emitters, Beta Emitters, Brachytherapy}), By Application (Oncology, Cardiology, Neurology, Orthopedics, Thyroid) And Region
... at USD 7.8 billion in 2021 and it is anticipated to grow up to USD 48.8 billion by 2031, at a CAGR of 20.1% during the forecast period. Nuclear medicine is primarily a specialized area ... Read More
Research Assistance
